Evidence map›Paper›PMID 38577158›Full record

ArticleFrontiers in nutrition2024

Effect of the consumption of brazzein and monellin, two recombinant sweet-tasting proteins, on rat gut microbiota.

Vladimir A Veselovsky, Daria I Boldyreva, Evgenii I Olekhnovich, Ksenia M Klimina, Vladislav V Babenko, Natalia V Zakharevich, Andrey K Larin, Maxim D Morozov, Polina Y Zoruk, Petr V Sergiev and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Vladimir A VeselovskyLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Daria I BoldyrevaLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Evgenii I OlekhnovichLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Ksenia M KliminaLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Vladislav V BabenkoLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Natalia V ZakharevichLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Andrey K LarinLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Maxim D MorozovLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Polina Y ZorukLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Petr V SergievA.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Olga A DontsovaA.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, Russia.
Igor V MaevDepartment of Propaedeutics of Internal Diseases and Gastroenterology, Moscow State University of Medicine and Dentistry, Moscow, Russia.
Tamara S NovikScientific Research Centre Pharmbiomed, Moscow, Russia.
Anatoly A KotlobayLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Vassili N LazarevLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Maria A LagarkovaLopukhin Federal Research and Clinical Centre of Physical-Chemical Medicine, Moscow, Russia.
Research Institute of Physical Chemical Medicine · RULomonosov Moscow State University · RUHydrometeorological Research Centre of Russian Federation · RUMoscow State University of Medicine and Dentistry · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sweet-tasting proteins (SPs) are proteins of plant origin initially isolated from tropical fruits. They are thousands of times sweeter than sucrose and most artificial sweeteners. SPs are a class of proteins capable of causing a sweet taste sensation in humans when interacting with the T1R2/T1R3 receptor. SP thaumatin has already been introduced in the food industry in some countries. Other SPs, such as monellin and brazzein, are promising products. An important stage in researching SPs, in addition to confirming the absence of toxicity, mutagenicity, oncogenicity, and allergenic effects, is studying their influence on gut microbiota. In this paper we describe changes in the composition of rat gut microbiota after six months of consuming one of two recombinant SPs-brazzein or monellin. A full length 16S gene sequencing method was used for DNA library barcoding. The MaAsLin2 analysis results showed noticeable fluctuations in the relative abundances of

Indexed as

food additiveintestinal bacteriamicrobiomemicrobiota compositionnatural sweetenersafetysugar substitutesymbiotic microorganism

Identifiers

PMID38577158
PMCPMC10991754
OpenAlexW4393053971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.